Volume 46, Issue 12 e14465
ORIGINAL ARTICLE

Nerolidol assists Cisplatin to induce early apoptosis in human laryngeal carcinoma Hep 2 cells through ROS and mitochondrial-mediated pathway: An in vitro and in silico view

Vaitheeswari Balakrishnan

Vaitheeswari Balakrishnan

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, India

Search for more papers by this author
Sindhu Ganapathy

Corresponding Author

Sindhu Ganapathy

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, India

Department of Biochemistry, Government Arts College (Autonomous), Kumbakonam, India

Correspondence

Sindhu Ganapathy, Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608 002, Tamilnadu, India.

Email: [email protected]

Search for more papers by this author
Vinothkumar Veerasamy

Vinothkumar Veerasamy

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, India

Search for more papers by this author
Ramachandhiran Duraisamy

Ramachandhiran Duraisamy

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, India

Search for more papers by this author
Saranya Jawaharlal

Saranya Jawaharlal

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, India

Search for more papers by this author
Vennila Lakshmanan

Vennila Lakshmanan

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, India

Search for more papers by this author
First published: 13 October 2022
Citations: 9

Abstract

The objective of this study was to examine Nerolidol (NER) and Cisplatin (CIS) performed against human laryngeal carcinoma (Hep 2) cells. We evaluated the effect of NER, CIS, and NER + CIS on cell viability, cell migration, oxidative stress, mitochondrial membrane depolarization, nuclear condensation, apoptotic induction, and DNA damage in Hep 2 cells. We used the MTT assay to assess the cytotoxicity effect of NER and CIS on Hep 2 cells in terms of morphological alterations. Present results demonstrated that IC50 values of NER and CIS have potential cytotoxicity against Hep 2 cells. NER effectively inhibited cell viability, increased reactive oxygen species generation, apoptotic induction, and DNA damage in Hep 2 cells. In addition, the docking study evaluated the structural binding interaction of NER with PI3K/Akt and PCNA protein. Furthermore, NER with PI3K/Akt, PCNA has a higher crucial score and affinity. Present results infer that NER could be used to target signaling molecules in anticancer studies.

Practical applications

Nerolidol is a dietary phytochemical with high biological activity that can find in a variety of plants. Many researchers focused on Nerolidol to treat various diseases including cancer. However, there is no studies exist on laryngeal cancer. This study uses Nerolidol and Cisplatin to generate oxidative stress and stimulate apoptosis and DNA damage in human laryngeal cancer cells. Based on present findings, Nerolidol could be a choice of anticancer medication, either alone or in combination against oral squamous cell carcinomas in both in vitro and in vivo experimental systems.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

DATA AVAILABILITY STATEMENT

The data supporting this study's findings are available on request from the corresponding author.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.